These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36932129)
61. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. El-Serag HB; Davila JA Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699 [TBL] [Abstract][Full Text] [Related]
62. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma. Anysz-Grodzicka A; Podgorska J; Cieszanowski A Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878 [TBL] [Abstract][Full Text] [Related]
63. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma. Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319 [TBL] [Abstract][Full Text] [Related]
73. [Fibrolamellar liver cell cancer. A case report]. Kahle M; Heilmann KL; Filler RD Z Gastroenterol; 1989 Jun; 27(6):341-3. PubMed ID: 2549740 [TBL] [Abstract][Full Text] [Related]
74. Connective tissue content of fibrolamellar carcinoma and other human liver tumors. Sárosi I; Kiss A; Schaff Z; Lapis K Acta Microbiol Hung; 1991; 39(4):321-31. PubMed ID: 1668900 [TBL] [Abstract][Full Text] [Related]
75. Fibrolamellar carcinoma of the liver. Yamaguchi R; Tajika T; Kanda H; Nakanishi K; Kawanishi J Hepatogastroenterology; 1999; 46(27):1706-9. PubMed ID: 10430327 [TBL] [Abstract][Full Text] [Related]
76. Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report. Kang S; Magliocca J; Sellers M; Roccaro G; Zheng W; Pectasides M; Draper A; Guadagno J; El-Rayes B; Akce M Oncol Res Treat; 2022; 45(7-8):430-437. PubMed ID: 35537414 [TBL] [Abstract][Full Text] [Related]
77. Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA. Neumayer C; Ng D; Jiang CS; Qureshi A; Lalazar G; Vaughan R; Simon SM Clin Cancer Res; 2023 Jan; 29(1):271-278. PubMed ID: 36302174 [TBL] [Abstract][Full Text] [Related]
78. A case of fibrolamellar cancer with a palliative response and minor radiographic regression with erlotinib and bevacizumab combination therapy. Fakih M Am J Ther; 2014; 21(6):e207-10. PubMed ID: 23676344 [TBL] [Abstract][Full Text] [Related]